The George Washington University, A Congressionally Chartered Not-For-Profit Corporation;The Board of Trustees of the University of Illinois
发明人:
申请号：
EP18776871.8
公开号：
EP3600295A1
申请日:
2018.03.29
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present disclosure provides compounds represented by Formula (I): (Formula(I) and pharmaceutically acceptable salts, solvates, e.g., hydrates, and prodrugs thereof, wherein X and n are as defined as set forth in the specification. The present disclosure also provides compounds of Formula (I) for use to treat diseases and conditions, e.g., cancer, wherein inhibition of HDAC provides a benefit.
